DOJ 2022 False Claims Act Settlements and Judgments: Learning Points

Episode Date: March 22, 2023

In this episode of Stark Integrity, Bob Wade (“Captain Integrity”) reviews the Department of Justice’s 2022 False Claims Act (FCA) settlements and judgments, highlighting key trends and lessons for healthcare organizations.

Bob provides both a high-level overview and practical insights into how FCA enforcement continues to shape compliance risk across the industry.

Overview of 2022 FCA Activity

Bob begins by emphasizing that FCA enforcement remains a significant and growing area of risk.

He notes that:

• Settlement amounts continue to be substantial
• Healthcare remains a primary focus of enforcement
• The government is actively pursuing a wide range of compliance issues

The takeaway is clear—FCA exposure is not diminishing, and organizations must remain vigilant.

The Role of Qui Tam Actions

A major theme in the episode is the continued importance of qui tam (whistleblower) actions.

Bob explains that:

• A large percentage of FCA cases originate from whistleblowers
• Employees and insiders play a central role in identifying potential violations
• The government often relies on these cases to drive enforcement activity

This underscores the importance of maintaining strong internal compliance programs to identify and address issues before they escalate externally.

Key Risk Areas in 2022

Bob highlights several recurring areas of FCA risk, particularly within healthcare.

These include:

• Medical necessity and documentation issues
• Improper billing and coding practices
• Financial relationships that may implicate Stark Law and Anti-Kickback concerns

These areas often overlap, creating layered compliance risk that can lead to significant exposure if not properly managed.

The Cost of Non-Compliance

One of the most important takeaways from Bob’s discussion is the true cost of FCA violations.

He notes that organizations facing FCA claims may encounter:

• Significant financial settlements
• Legal and investigative costs
• Reputational damage
• Ongoing oversight obligations

Even beyond the settlement amounts, the broader impact can be substantial and long-lasting.

Government Focus and Enforcement Trends

Bob also highlights how the government continues to refine its enforcement strategies.

He explains that:

• Enforcement efforts are becoming more targeted and sophisticated
• Data analytics and audits are increasingly important tools
• Collaboration across agencies enhances enforcement effectiveness

These trends suggest that healthcare organizations must be more proactive than ever in managing compliance risks.

Importance of Proactive Compliance

A key message throughout the episode is that organizations cannot afford to be reactive.

Bob emphasizes that effective compliance programs should:

• Identify risks early through auditing and monitoring
• Encourage internal reporting and transparency
• Address issues promptly before they escalate

Proactive compliance is essential to reducing the likelihood of FCA exposure.

Practical Takeaways

The key takeaway from this episode is that FCA risk remains a central compliance concern, requiring ongoing attention and proactive management. Organizations should:

• Understand the most common areas of FCA exposure
• Strengthen internal reporting and whistleblower response processes
• Conduct regular audits and risk assessments
• Ensure documentation and billing practices are accurate and defensible
• Address potential issues quickly and thoroughly

Final Thoughts

This episode reinforces that the False Claims Act continues to be one of the most powerful enforcement tools in healthcare compliance.

Bob’s review of 2022 settlements makes clear that organizations must take a proactive, disciplined approach to compliance in order to mitigate risk and navigate an increasingly complex enforcement environment.

Click here to listen to this Stark Integrity Podcast Episode:
https://podcasts.apple.com/us/podcast/doj-2022-false-claims-act-settlements-and-judgments/id1588939373?i=1000601032170&l=fr-FR